Mereo BioPharma Group plc Strategic Asset Allocation Index
Mereo BioPharma Group plc strategic asset allocation index. Mereo BioPharma Group plc (MAH0) has a Strategic Asset Allocation Index of 2.7% as of June 2023. Strategic assets (PP&E of €1.56 Million plus long-term investments of €-) total €1.56 Million, measured against net assets of €57.74 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See MAH0 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Mereo BioPharma Group plc (2016–2022)
Strategic asset allocation index of Mereo BioPharma Group plc from 2016 to 2022. This chart shows how Mereo BioPharma Group plc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2022. As of June 2023, the index stands at 2.7%, representing strategic assets of €1.56 Million against net assets of €57.74 Million EUR. Check Mereo BioPharma Group plc (MAH0) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Mereo BioPharma Group plc Strategic Asset Allocation Index by Year (2016–2022)
Mereo BioPharma Group plc strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Mereo BioPharma Group plc from 2016 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Mereo BioPharma Group plc stock valuation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.0% | €1.83 Million | €1.83 Million | €- | €61.87 Million | ▲ +0.1 pp |
| 2021 | 2.9% | €2.53 Million | €2.53 Million | €- | €88.00 Million | ▼ -25.8 pp |
| 2019 | 28.7% | €11.56 Million | €11.56 Million | €- | €40.26 Million | ▲ +28.3 pp |
| 2018 | 0.5% | €149.00K | €149.00K | €- | €32.77 Million | ▲ +0.2 pp |
| 2017 | 0.2% | €153.36K | €153.36K | €- | €62.48 Million | ▲ +0.0 pp |
| 2016 | 0.2% | €173.87K | €173.87K | €- | €79.26 Million | — |